Weiwei Du Email & Phone Number

Singapore

- Manage all the patient related data input/output, analytics and performance KPIs. Worked with all therapeutic areas in Rare Diseases, Multiple Sclerosis and Immunology, across all EM geographies to ensure that data input is correct, output meaningful and KPIs are measurable and can be shared on one platform by all parties via the QlikView GEM dashboard.-Work closely with ITS partners to modernize & atomize tools that enhance diagnosis, efficiency and productivity (e,g. DBS automation, Avarto automation). Support Patient Support Programs with the right tools and systems (e.g. PRM pilot)-Clean/Build the infrastructure of data mining to pave the road of innovative integrated care solutions (e.g. Fabry find expansion)-In charge of cross-disease and functional training in the entire emerging markets

Singapore

Responsible for the entire Genzyme operations in Asia including China:- Achieving sales and BOI target- In an integrated model, support country daily operations in Rare Diseases and Multiple Sclerosis in the areas of KOL engagement, Diagnosis enhancement, Launch preparedness, Market Access, Patient support and operational excellence. -Lead immunology new product development and new product launch business case process

Paris Area, France

Manage the office of Executive VP of Pharma business of the Sanofi Group: 25 Bio € sales, 47 000 people, 100 plus countries for a diversified business. High and deep exposure to complex business scenarios around the world. • Responsible for organizing and coordinating Global Commercial Operations governance including key meetings with the Executive Committee, Commercial Operations Committee and with Global Divisions.• Member of the Global Commercial Operations Leadership Team and a member in various management committees. Provided input in Global Commercial Operations’ decision making and worked on strategic projects.

Singapore

Leading the Consumer Healthcare business in the heterogeneous Asia Pacific & Japan region (original scope was 500M Euros including India and Russia). Created the platform from scratch and managed multi-national teams across a dozen of countries, 8 categories and 10 major brands• Responsible for overall business strategies and tactical plans via organic growth as well as targeted acquisitions (Australia) and partnership (Japan & Indonesia)• In charge of portfolio management, brand management, new product development and life cycle management. Streamlined portfolio and created 3 year rolling NPD and marketing programs for all major brands from scratch. • Responsible for country operations/sales by working closely with GMs and other functions. Optimized country CHC structures. Co-responsible for P&L and resource allocation to drive the best return. Leader of COGs reduction projects to achieve optimal margin.

Singapore

Head of multiple major projects covering different countries and diverse businesses in the region• Pioneered “Innovation for Life” program, a new, equitable and sustainable tiered-pricing business model that gives greater access to the most innovative drugs in diabetes and oncology to lower-tier patients in South East Asia countries. The program benefits up to 100 million patients and generates additional business and positive PR. Exclusive interview with Financial Times thanks to project uniqueness and achievement• Played key role in the acquisition of Australia’s biggest VMS business (Symbion including brands such as Nature’s Own and Cenovis) and was member of the committee overseeing the successful integration of all functions and facilities. • Successfully headed the VMS expansion of acquired brands in 3 Asian countries including market entry strategy, brand positioning, building local operational team, new product development and commercialization.

New York City

Worked at the Maybelline global headquarters and across all categories. Oversaw all aspects of marketing and product/business development of the $1.7 billion world #1 cosmetics brand between the headquarters, zones and countries. Direct zone responsibilities for Canada.• Ensured that brand development conforms to global strategy and strategies are impeccably executed. Pioneered the seasonal cross-category worldwide in-store campaigns and handled from concept to commercialization. Leader of international logistics coordination and world sampling programs. • Responsible for sales excellence sharing. In charge of building the digital best practice/data portal and creating global training materials. • In charge of forecasting, business analysis and performance KPI follow-up. Monitored competitive activities and propose new products ideas.

New York City

Revitalized the leading brands in cosmeceutical skincare market. Turned sales around from -14% to +5% in the professional channel (selling directly to dermatologists and plastic surgeons). The launch of Biomedic 21-Day Intensive Treatments revolutionized the skincare industry – it was copied by all the major skincare brands around the world in all channels.• Defined and implemented strategies to reposition the brands, streamline product portfolio, enhance product packaging and better customer service/communication. Key member of the manufacture transition project to transfer all manufacturing from California to New Jersey.• Paved the retail expansion of La Roche-Posay in the drug store channels by successfully registering Anthelios, an innovative sun protection formula and worked with key retailer CVS to pioneer the first “shop in shop” concept in the US.

New York City

• Successfully launched Eligard, late-stage anti-prostate cancer drug in a highly competitive market. Defined customized strategies to market the same product to two different groups of professionals. Interacted with license holder/manufacturer to maximize sales and accelerate new product registration. • Developed and implemented strategic and tactical business plans. Worked on all aspects of marketing: KOL management, product management, convention, advertising, education, sales marketing materials.

Paris

Worked at the global operation level on budgets and plans. Defined and followed up the performance indicators. Analyzed major operational expenditures in order to determine requisite return on investment. • Participated in cross functional and special projects, responsible for proposing operational and organizational improvements. • Interfaced with Global Marketing, International Pricing and Industrial Affairs on international product pricing strategies for major launches.

Shanghai

Established the HR Department from scratch. Successfully satisfied the needs of rapid affiliate expansion from 40 to 400 persons within 2 years. Managed all HR aspects of the merger and integration of Synthelabo into Sanofi. • Created procedures related to recruitment, compensation/benefits and career development. Built electronic salary system that links internal cost centers and external banking system.• Frequently negotiated with governmental labor organizations to maximize employee benefits and minimize tax. Initiated first pharmaceutical industry C/B panel in China.

Hangzhou

Participated in the process of establishing the JV between Sanofi and Minsheng. • Assisted the GM in all aspects of operations (translation in management meetings and documents). Assisted in upgrading the factory and obtaining GMP certification.• Oversaw all administration activities. Responsible for internal and external communication. Organized “French Exhibition 97” in Shanghai for Sanofi as a major exhibitor.

Master Of Business Administration (Mba)

Mba, Marketing And Finance

Bachelor, French And English Literature